focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Pumpkin, all the uber positive posters have a life and invested in a Company that is now clinical, we did not invest to waste our time engaging with idiots on LSE. People who decide their investments based on a few trolls on LSE or the intra day movements in share price deserve to lose everything. Funny how the larger shareholders are not wasting their time engaging, not AWOL just cant be bothered with the BS.
Good god Andy, literally 3 posts ago you put:
I find shares usually take about 3 days to properly rerate.
Exactly. So....?
MrI.... come on.
As I said before go back and look at performance after the Covid RNS, go check the Prevail placing RNS and check the charts in the subsequent days, then look at the past few days, then get the F off your computer and come back in a few days.
Hemogenyx are Clinical, any BS about a placing is just that, there WILL be fund raising but its not going to be some pathetic 2m at a discount Peterhouse special to the usual twitter flippers, IF it was you would see those bell ends on here trolling away constantly trying to get a lower price.
Dr S is silent, take it as a good sign. Chill the F out. Do you see any other large holders getting hot and bothered?
Subbush Yes I agree with you in principal, however to the best of my knowledge Prevail have been onboard for over a year now as Vlad made it clear in the interview last year and the video that the 3rd party were lined up and ready to sign. Part of that negotiation would have been finance and funding arrangements and a valuation PRE-clinical at which they are willing to come on board and fund. So at that point IMO the price was 6p, the valuation would not have changed just the timeline as the Clinical Hold then arrived out of the blue. When prevail invested 500k at 6p that would not have been planned, it would have been an out of the ordinary PRE-Clinical investment which Prevail just do not do. IMO for such a low number they would not have re-assessed the valuation or changed any paperwork and would have went with the pre-agreed price of 6p. So YES I agree now IND is approved Hemo is worth ALOT more, However, that is the reward you get for getting in early, Prevail have been in the wings for over a year and IMO they have been promised 6p and so will any strategic investors they have brought with them.
I could be wrong, but for me I am convinced Prevail will get 6p again.
Good god EVERY single RNS in every share and all we hear is "Placing!" YES there will be fund raising but 2mil from Peterhouse for a discount placing is NOT going to help hemogenyx. They need SIGNIFICANT cash, they need probably 10-20mil, which they will get now they are CLINICAL. But do not expect it to come from Peterhouse or the 2bit flippers from twitter. Prevail have been on the sidelines for a year waiting for IND approval. My guess is circa 6p AGAIN as that is the price they already agreed and are likely to get again this time around.
I have no idea why your here pumpkin, just a toxic individual. Telling everyone IND submission would be months away and tell us again how the FDA won't reply for another week?
Just sad and stuck in the past. I had hoped with hemo going clinical you would turn over a new leaf and maybe not dedicate every post to trolling hemo now? But nope, too much to ask.
Hopefully new investors who are now investing in a CLINICAL pharma company will post and drown out the old irrelevant negative trolls who genuinely don't want Hemo to do well and could not care less if people die waiting on a cure.
Haddy, sadly the drop back is consistent with past performance. Check out the prevail rns and the covid 19 RNSs. Huge volumes, massive rise and fallback intraday of release closing almost flat with the massive sustained rise in the following days. So don't be concerned that Friday closed flat, we have form.
Bottom line is there was 50m churn north of 4.5p, the trend is up.
Who sold? Everyone, even LTHers like myself have stated we would derisk after the company goes clinical so don't be surprised that many followed through, the SP never got high enough for me, my average is high I want double figures before I slice, but many with averages of 2pish? 4,5,6p is multibag territory. Add in traders and shorters ONLY here for IND and the drop back is easy to explain. But... the selling is done, history tells us what happens now.
The fears about placing are ill founded, Vlad CANNOT raise the levels needed for trials + CBR development via a public discount placing with peterhouse, why do you think the usual placee trolls have been quiet? Normally they can short and troll and buy back in a placing. This time they are not getting that chance.
Hemo will need 10-20mil, they need money, but that means strategic investment at a premium or JV or partnership NOT a discount Peterhouse special.
The cln instrument was a decaying share price there was no incentive to hold any shares, infact the more they forward sold and the lower they pushed the sp the better.
HOWEVER... There were shares short on IG and spreadex and perhaps the market makers had shares from pre CDX crash at those levels from Mint and that was the price they were willing to release them?
Sorry Haywain, too late its a done deal :-D
Myself and a few I know have more than 5%. However an EGM is for a bad thing, certainly not something like this which would just be really good
Haywain has more experience with INDs than our CEO who only popped his Clinical cherry 🍒 yesterday. 1000% I would vote for Haywain to join the Hemo team. He is respected by everyone, know the science and is able to dumb it for us simpletons. Basically he is in the goldilocks zone.
Https://www.fiercebiotech.com/biotech/biontech-pays-autolus-250m-manufacturing-car-t-expertise-wide-ranging-collab
Where as Hemogenyx with their own clean rooms will manufacture in house! But this is another example of the world hemo are joining.
Better question Island girl
"why our Car T cell Therapy is any different to the others"
Great question and as condom says it's a different target.... HOWEVER. Why should ours be any different to the rest? The rest which have been licenced for 500m or 1b? That cost 200k PER PATIENT?Nope no reason, none atall! 😁
For those who CBA to check the 2 dates provided or the associated charts. They are 2 of the biggest rises we have ever seen in Hemo off the back of good RNS. And guess what? NONE of them like today had a good RNS day. I hoped today would be different but nope, Hemo does poor RNS day followed by bumper days following. Wish this time was different but there you go, enjoy the weekend look forward to Monday!
500+ Posts!!?? Yea not a chance, see we have attracted some new trolls/traders/shorters never seen before but suddenly all over page 1 and 2 and I presume the other 25 pages from today?
Disappointing finish to the day is an understatement! But 100m traded with 50 million of those traded early hours above 4.5p, most above 5p. The gap up this morning will have seen the shorts closed out early doors, and looks like they and their friends piled in after reloading.
I dont give a toss who sold today, as I said earlier what I care about is who now buys and thanks to all those who sold today thats going to be much cheaper for them! Hemogenyx are now CLINICAL. I made a conscious decision to ignore the board and not get involved because honestly? I did not want to encourage any traders to buy or discourage any from selling, if you sold and did not buy back in then thats your decision, deal with it.
HEMO-CAR-T is now ready to be moved into Phase 1/2a clinical trials Pharma investors will invest for that alone. Funds and investors who have a life will start to be made aware that Hemogenyx are now Clinical and preparing to start trials and will hopefully take a position, Institutional Investors will hopefully slowly scale in now also.
Hemogenyx are now CLINICAL in a field where CAR-T demands licensing fees of up to1bn, and that can come as early as a few patients are cured. CAR-T small companies are all 100-300m+, Hemogenyx is an outlier by some significant margin, that will correct I am certain.
Today was expected a year ago, today unlocks Prevail who ONLY invest in CLINICAL companies (they made an exception for Hemo) and they can now invest in CAR-T. HUGE difference between a strategic long term investment Vs a discount placing via peterhouse. Today allows Prevail to actually set up the trial, keep an eye out on the clinical trials website, be prepared to see Hemo picked up by news papers. Today unlocks Vlad to progress CBR and CDX which he stated would pick up once they got IND approval for CAR-T.
Today was not the end or some magical finish line, this Clinical Hold was HOLDING up EVERYTHING, its gone, and if people really, genuinely believe this SP is going to hold you are crazy.
Go and look at the Chart for 9th Jan -> 18th Jan, then 22nd April to 1st May 2020. When your doing that look at what date the RNS was released on and have a look at what the SP did BOTH days and then in the following 2 days. Notice anything familiar? Like I said, if you sold deal with it, history has a habit of repeating itself.
No way am I engaging on a board this active, I have too much work today, Super happy with the update, am positive we will attract trolls and shorters and I just CBA engaging :P
Hemogenyx are NOW CLINICAL.
News will start to flow on Funding - Prevail last paid 6p, expect 6p+ for next cash injection
Prevail will launch the Trial, they wont hang around so in the next few weeks expect to see publication of the trial etc.
This unlocks Vlad for CBR and CDX.
Fears about IND are GONE (not that I had any)
This share WILL re-rate, they are now clinical. The price range for JUST an pharma in Phase 1 with CAR-T for cancer is 100-300m+ Thats 8-9p+ so a long way to go, but its starting now.
Dont really care who buys or sells today, this puts Hemo on the map for funds/II/SIs and more THEY are who I care about and I dont expect them to move at the drop of a hat. Roll on the weekend, because I WILL be having some of Tillys Grog tonight!
Good day to you all, and congratulations to all LTH'ers who never gave up hope
Buy at any price... and still shorts open.
This could get messy lol
Will do pig, that will do. :)
Or just don't check your mail until after 5pm 😀
If it arrives say 2pm new York then by the time vlad prepares a rns, has it approved by the fellow board members and signed off it could easily be too late to RNS.... yes he has a duty to update the market, but he is allowed to take a few hrs or even a day to make sure its done right. PROVIDED he keeps it confidential until then.